Roth Priscila Vernizi, Drizlionoks Renata, Antunes Rafaela Cachiolo, Crippa Ana Chrystina Souza, Morgan Mariana Aparecida Pasa, Carvalho Vânia Oliveira de
Department of Pediatrics, Complexo do Hospital de Clínicas da Universidade Federal do Paraná, Curitiba, PR, Brazil.
Sleep Sci. 2024 May 29;18(1):e97-e103. doi: 10.1055/s-0044-1787275. eCollection 2025 Mar.
To investigate sleep disorders among children with atopic dermatitis (AD), before and during the coronavirus disease 2019 (COVID-19) pandemic. The present longitudinal, prospective study included 26 patients with AD, and the Sleep Disturbance Scale for Children (SDSC) questionnaire and questions about sleep hygiene were used. The severity of AD was determined by the Patient-Oriented Eczema Measure (POEM). The first evaluation was conducted before the pandemic (in 2019) and the second, during the pandemic, from September to December 2020. Sleep disorder was present in 17 (65.38%) patients in the 1st evaluation, and in 11 (42.30%) in the 2nd ( = 0.04). In the 1st evaluation, disorders of initiating and maintaining sleep (DIMSs) were more frequent in patients with moderate-to-severe AD (83.33%). During the pandemic, 6 patients (23.07%) reported improvement in sleep quality. Sleep quality was negatively influenced by the severity of AD. During the COVID-19 pandemic, there was improvement in sleep quality, despite the absence of changes in disease severity.
调查2019冠状病毒病(COVID-19)大流行之前及期间特应性皮炎(AD)患儿的睡眠障碍情况。 本纵向前瞻性研究纳入了26例AD患儿,并使用了儿童睡眠障碍量表(SDSC)问卷以及关于睡眠卫生的问题。AD的严重程度通过患者导向性湿疹评估量表(POEM)来确定。首次评估在大流行之前(2019年)进行,第二次评估在大流行期间,即2020年9月至12月进行。 第一次评估时有17例(65.38%)患者存在睡眠障碍,第二次评估时有11例(42.30%)存在睡眠障碍(P = 0.04)。在第一次评估中,中度至重度AD患者中入睡和维持睡眠障碍(DIMSs)更为常见(83.33%)。在大流行期间,6例患者(23.07%)报告睡眠质量有所改善。 睡眠质量受到AD严重程度的负面影响。在COVID-19大流行期间,尽管疾病严重程度没有变化,但睡眠质量有所改善。